Company Filing History:
Years Active: 2016
Title: Innovations of Eric Peters in Bioconjugates
Introduction
Eric Peters is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of bioconjugates, particularly in the development of synthetic apelin polypeptides. His work focuses on therapeutic applications that address various cardiovascular and metabolic conditions.
Latest Patents
Eric Peters holds a patent for "Bioconjugates of synthetic apelin polypeptides." This invention provides bioconjugates comprising a synthetic polypeptide of a specific formula, which includes a half-life extending moiety. The polypeptides act as agonists of the APJ receptor and have potential therapeutic uses in treating conditions such as acute decompensated heart failure, chronic heart failure, pulmonary hypertension, and several other serious health issues.
Career Highlights
Eric Peters is currently associated with Novartis AG, a leading global healthcare company. His innovative work in the field of bioconjugates has positioned him as a key figure in the development of new therapeutic agents. His research has the potential to significantly impact the treatment of various cardiovascular diseases and metabolic disorders.
Collaborations
Eric has collaborated with notable colleagues, including Jun Yuan and Frederic Zecri. These partnerships have enhanced the scope and impact of his research, contributing to advancements in the field of bioconjugates.
Conclusion
Eric Peters is a prominent inventor whose work in bioconjugates has the potential to revolutionize treatments for numerous health conditions. His contributions to the field are invaluable and highlight the importance of innovation in healthcare.